Skip to main content

Your search for “pharmacology” returned 290 results

NIH Awards UC San Diego $33 Million for Five COVID-19 Diagnostic Projects

February 25, 2021

UC San Diego was awarded five COVID-19 Rapid Acceleration of Diagnostics (RADx) projects by the National Institutes of Health totaling nearly $33 million, which will fund efforts that range from managing a large data center to expanding testing in disadvantaged communities.

In Mice, Eliminating Damaged Mitochondria Alleviates Chronic Inflammatory Disease

April 11, 2019

Treatment with a choline kinase inhibitor prompts immune cells to clear away damaged mitochondria, thus reducing NLRP3 inflammasome activation and preventing inflammation

Digitized Number 2: Stool Samples Reveal Microbial Enzyme Driving Bowel Disease

January 27, 2022

Researchers at UC San Diego used a multi-omics approach to investigate stool samples from patients with ulcerative colitis, a chronic inflammatory bowel disease. The team has identified the family of microbiome-derived enzymes driving the disease, and demonstrated a potential therapeutic solution.

UC San Diego Awarded $8 Million to Uncover Genetic Foundations of Substance Use Disorders

October 28, 2024

UC San Diego has received a five-year, $8 Million grant to support a NIDA P30 Center to investigate the genetics, genomics, and epigenetics behind substance use disorders.

Researchers Map Druggable Genomic Targets in Evolving Malaria Parasite

January 11, 2018

Researchers at University of California San Diego School of Medicine, with colleagues across the country and around the world, have used whole genome analyses and chemogenetics to identify new drug targets and resistance genes in 262 parasite cell lines of Plasmodium falciparum — protozoan pathogens that cause malaria — that…

New Method Allows Scientists to Screen Natural Products for Antibiotics

December 8, 2015

Biologists at UC San Diego have found that a method they developed to identify and characterize new antibiotics can be employed to screen natural products quickly for compounds capable of controlling antibiotic resistant bacteria.

New Way of Fighting High Cholesterol Upends Assumptions

September 27, 2012

Atherosclerosis has been presumed to be the consequence of complicated interactions between overabundant cholesterol and resulting inflammation in the heart and blood vessels. Researchers at the University of California, San Diego School of Medicine, with colleagues at institutions across the country, say the relationship is not exactly what it appears,…

Vital Protein Complex and Therapeutic Possibilities Revealed

September 28, 2011

Three international teams of scientists, led by researchers at the University of California San Diego, University of Michigan and Stanford University, have published a trio of papers describing in unprecedented detail the structure and workings of G protein-coupled receptors (GPCRs), a large family of human proteins that are the target…

For Geoffrey Chang, New Project Studying Tiny Proteins Has Big Personal Impact

January 16, 2020

…the Skaggs School of Pharmacology and Pharmaceutical Sciences, his research has included studying transporter structures in cell membranes that are so small, they are most easily studied using X-ray crystallography, the same technique used to unravel the structure of DNA. “I study all kinds of things,” he said. “Molecules in…

John Wooley: In Memoriam

May 5, 2015

Dr. John Wooley, the long-time associate vice chancellor for research and professor of pharmacology at the University of California, San Diego, passed away in April after a long battle with cancer.

Category navigation with Social links